trending Market Intelligence /marketintelligence/en/news-insights/trending/kWb_GxdaJTvwsmoO0yM09g2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Imprimis Pharmaceuticals changes name to Harrow Health

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

Blog

COVID-19 Impact & Recovery: Investment Banking


Imprimis Pharmaceuticals changes name to Harrow Health

Imprimis Pharmaceuticals Inc. said it changed its name to Harrow Health Inc. and will trade as HROW on the Nasdaq Capital Markets beginning Jan. 2, 2019.

Harrow Health owns a portfolio of healthcare businesses, including an ophthalmology pharmaceutical compounding business called ImprimisRx.